Athersys
ATHX
#10561
Rank
NZ$1.43 M
Marketcap
NZ$0.02325
Share price
-33.50%
Change (1 day)
-98.91%
Change (1 year)

Earnings for Athersys (ATHX)

Earnings in 2023 (TTM): -NZ$67.38 Million

According to Athersys's latest financial reports the company's current earnings are NZ$0.08 Million. In 2022 the company made an earning of -NZ$0.14 Billion, an increase over its 2021 earnings that were of -NZ$0.15 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Athersys from 2007 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -NZ$67.38 Million-49.19%
2022 -NZ$0.14 Billion-11.54%
2021 -NZ$0.15 Billion11.14%
2020 -NZ$0.14 Billion72.2%
2019 -NZ$78.34 Million77.29%
2018 -NZ$44.19 Million-22.91%
2017 -NZ$57.32 Million111.89%
2016 -NZ$27.05 Million-8.52%
2015 -NZ$29.57 Million-40.81%
2014 -NZ$49.96 Million18.62%
2013 -NZ$42.12 Million
2011 -NZ$23.73 Million19.71%
2010 -NZ$19.83 Million-26.28%
2009 -NZ$26.89 Million-18.21%
2008 -NZ$32.88 Million-8.28%
2007 -NZ$35.85 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
NZ$14.19 B-19,840.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$20.40 B-28,479.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$13.83 B-19,335.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
-NZ$5.42 Billion 7,430.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$55.78 B-77,672.91%๐Ÿ‡บ๐Ÿ‡ธ USA
United States Lime & Minerals
USLM
NZ$0.28 B-496.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Arena Pharmaceuticals
ARNA
-NZ$1.08 Billion 1,401.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$39.76 B-55,389.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$15.67 B-21,890.77%๐Ÿ‡ซ๐Ÿ‡ท France